Cryptocurrency

Volcon (VLCN) now holds 3,183.37 BTC, acquired for approximately $375 million at an average of $117,697 per Bitcoin. The company is actively managing its position by selling short-term put contracts to potentially acquire more Bitcoin at lower prices. Volcon’s board has also authorized a $100 million stock repurchase program. The company believes this treasury strategy reflects its confidence in Bitcoin as a long-term store of value. Volcon aims to offer investors efficient exposure to Bitcoin through the public equity market.

Belgravia Hartford Capital Inc. (BLGV) has announced its largest single-day Bitcoin purchase, acquiring 25.03 BTC funded entirely by a recent CAD $4,022,955.55 private placement. This increases Belgravia’s total BTC holdings to 40.7719114, yielding a 13% return since June 5, 2025. The purchases were executed via Coinsquare’s OTC desk. Belgravia plans further BTC acquisitions, deploying an additional USD $5M upon closing an agreement with Round13.

LUXXFOLIO Holdings (CSE: LUXX) increased its Litecoin treasury to 20,084 LTC, a 151.6% Litecoin-per-share yield. The company closed a $2.5 million financing and deployed 841 cbLTC into decentralized liquidity protocols for yield generation. LUXXFOLIO is advancing Litecoin infrastructure development and remains debt-free. Geoff Balderson replaced Geoff McCord as CFO and Director. They are focusing on stablecoin payments and yield.

Sixty Six Capital Inc. is increasing its Bitcoin holdings, acquiring 18.2 BTC for CAD$2,634,450 and planning to convert its BTCC.B ETF holdings to direct BTC ownership. The company will also launch a private placement financing to raise USD$2.5 million for further Bitcoin acquisitions and operational expenses. This strengthens its commitment to the digital asset space.

Eyenovia, Inc. is pivoting into the digital asset space with a $50 million private placement to acquire over 1,000,000 HYPE tokens from Hyperliquid, becoming the first U.S.-based public company to hold a substantial amount. This investment, coupled with the appointment of a Chief Investment Officer, positions Eyenovia as a top-tier validator. Simultaneously, Eyenovia will continue ophthalmic technology development, reflecting a dual strategy to create value, while also launching a HYPE staking program. The company is planning to change its name and ticker.